DRUG-INDUCED OSTEOPOROSIS

被引：34
|
作者：
MAZANEC, DJ
GRISANTI, JM
机构：
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 1989年 / 56卷 / 03期
关键词：
D O I：
10.3949/ccjm.56.3.297
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：297 / 303
页数：7
相关论文
共 50 条
  • [1] Drug-induced osteoporosis
    de la Cour, D. P. D.
    SA PHARMACEUTICAL JOURNAL, 2010, 77 (09) : 35 - 40
  • [2] Drug-induced osteoporosis: Beyond glucocorticoids
    Briot K.
    Roux C.
    Current Rheumatology Reports, 2008, 10 (2) : 102 - 109
  • [3] Drug-induced osteoporosis risk confirmed
    不详
    GERIATRIC NURSING, 2002, 23 (02) : 61 - 61
  • [4] Drug-Induced Osteoporosis beyond Glucocorticoids
    Finkenstedt, G.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (01): : 38 - 43
  • [5] Drug-induced Osteoporosis: Mechanisms and Clinical Implications
    Mazziotti, Gherardo
    Canalis, Ernesto
    Giustina, Andrea
    AMERICAN JOURNAL OF MEDICINE, 2010, 123 (10): : 877 - 884
  • [6] Pathophysiology of drug-induced osteoporosis and osteoporosis in inflammatory systemic rheumatic diseases
    Patschan, D
    Buttgereit, F
    AKTUELLE RHEUMATOLOGIE, 2001, 26 (03) : 95 - 100
  • [7] Medications with Negative Effect on Bone - Drug-Induced Osteoporosis
    Gasser, R. W.
    Gotsch, C.
    JOURNAL FUR MINERALSTOFFWECHSEL & MUSKULOSKELETTALE ERKRANKUNGEN, 2016, 23 (03): : 78 - 85
  • [8] Drug-induced osteoporosis: from Fuller Albright to aromatase inhibitors
    Byreddy, D. V.
    Bouchonville, M. F., II
    Lewiecki, E. M.
    CLIMACTERIC, 2015, 18 : 39 - 46
  • [9] Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview
    Wang, Li-Ting
    Chen, Li-Ru
    Chen, Kuo-Hu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [10] REAL LIFE RISK OF FRACTURE AND TREATMENT PREVALENCE IN DRUG-INDUCED OSTEOPOROSIS
    Adami, G.
    Giollo, A.
    Benini, C.
    Orsolini, G.
    Viapiana, O.
    Gatti, D.
    Fassio, A.
    Rossini, M.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S166 - S167
12345